Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Tectonic Therapeutic (TECX) Equity Average (2018 - 2026)

Tectonic Therapeutic (TECX) has 9 years of Equity Average data on record, last reported at $240.9 million in Q1 2026.

  • On a quarterly basis, Equity Average rose 9.04% to $240.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $240.9 million, a 9.04% increase, with the full-year FY2025 number at $196.1 million, up 598.44% from a year prior.
  • Equity Average reached $240.9 million in Q1 2026 per TECX's latest filing, down from $259.4 million in the prior quarter.
  • Over the last five years, Equity Average for TECX hit a ceiling of $292.4 million in Q2 2025 and a floor of -$92.1 million in Q1 2024.
  • A 5-year average of $98.9 million and a median of $130.8 million in 2022 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: tumbled 413.56% in 2023, then surged 775.54% in 2025.
  • Tracing TECX's Equity Average over 5 years: stood at $26.2 million in 2022, then crashed by 413.56% to -$82.2 million in 2023, then skyrocketed by 277.07% to $145.6 million in 2024, then surged by 78.22% to $259.4 million in 2025, then dropped by 7.15% to $240.9 million in 2026.
  • Business Quant data shows Equity Average for TECX at $240.9 million in Q1 2026, $259.4 million in Q4 2025, and $275.6 million in Q3 2025.